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Abstract
Introduction: The incidence of infective endocarditis (IE) in pregnancy is rare and has
been increasing during the opioid epidemic. IE in pregnancy is associated with high rates
of maternal and fetal morbidity and mortality. Multidisciplinary endocarditis teams for
management of IE have been shown to reduce in-hospital and 1-year mortality. We present a
single-center experience managing IE in pregnancy utilizing a multidisciplinary endocarditis
team.
Methods: Patients diagnosed with IE while pregnant or within 30 days post-partum were
identified. All patients discussed at the institution’s weekly multidisciplinary endocarditis
meeting were included. Demographic and clinical data and outcome-related variables were
retrospectively reviewed and recorded.
Results: Between 1 October 2020 and 1 June 2021 6 pregnant or 30-day post-partum patients
with IE were identified. All patients had co-morbid injection drug use; Staphylococcus aureus
was the etiologic pathogen in all patients. All patients had embolic complications and 5
required ICU admission and mechanical ventilatory support. Four patients underwent valve
replacement. There were no patient-directed discharges. All patients survived to hospital
discharge and 90-days after diagnosis. Four pregnancies resulted in delivery at an average
gestational age of 32.4 weeks with 3 requiring NICU admissions and prolonged lengths of
stay. All patients were seen by addiction medicine and 5 were started on medication-assisted
treatment for opioid use disorder.
Discussion: In a small retrospective cases series, coordination of care by a multidisciplinary
endocarditis team led to a high-rate of surgical intervention with no patient-directed
discharges and no in-hospital or 90-day mortality.
Conclusion: Multidisciplinary endocarditis teams are a low-risk intervention that may improve
outcomes in pregnant patients with IE.
Keywords: endocarditis, injection drug use, multidisciplinary team, pregnancy
Received: 12 October 2021; revised manuscript accepted: 29 January 2022.

Introduction
Infectious endocarditis in pregnancy can present
challenging management dilemmas. While the
reported incidence is rare (0.006%), there has
been an uptrend in endocarditis complicating
pregnancies with the current opioid epidemic.1–3
The cardiovascular physiology adaptations to
pregnancy confer a substantial risk of hemodynamic collapse with acute valve failure secondary
to endocarditis. Maternal mortality reports have

ranged from 10% to 33% with recent studies
demonstrating improving outcomes, likely due to
early recognition and prompt initiation of treatment.1,3,4 Fetal mortality from maternal endocarditis in the United States may be as high as
14.6%.3 In addition, more than half of deliveries
complicated by endocarditis are pre-term with an
average gestational age of 32.4 weeks, with further
morbidity associated with prematurity.5 While
maternal outcomes from cardiac surgery are
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reportedly similar to non-pregnant women, current literature on management is limited to case
series and retrospective reviews and data on neonatal outcomes have not been characterized.3,6,7
Discussions regarding indications and timing of
valve surgery are particularly complex given poor
fetal outcomes with cardiopulmonary bypass.6,7
Consequently, delivering effective care often
requires coordination among several specialties.
Multidisciplinary endocarditis teams for management of infective endocarditis have been shown to
reduce in-hospital and 1-year mortality.8,9
However, the impact of this approach on the
pregnant/peripartum population has not been
previously studied. We present a 1-year singlecenter experience managing IE in pregnancy utilizing a multidisciplinary endocarditis team.
Methods
Patient cases
Ethical approval was obtained from the University
of Pittsburgh. Institutional Rreview Board (IRB
#20090137). Patient consent was not required as
the study was exempted by the IRB. Consecutive
patients diagnosed with infectious endocarditis
while pregnant or within 30-days post-partum
and whose cases were discussed at the institution’s weekly multidisciplinary endocarditis meeting were enrolled. Patient management plans
were finalized by the endocarditis team, comprised of faculty from the departments of cardiac
surgery, cardiology, infectious diseases, neurology, psychiatry and addiction medicine with ad
hoc contributions from obstetrics and gynecology. Patient data were retrospectively reviewed by
a study investigator not involved in the patients’
care. Demographic, clinical and outcomes related
variables were recorded.
Multidisciplinary endocarditis team
The multidisciplinary endocarditis team at the
University of Pittsburgh Medical Center’s
(UPMC) Presbyterian and Montefiore hospitals
was initially created in September 2019. In
September 2020 an infectious diseases consult
service, known as the endovascular infections
team (EVI), dedicated specifically to caring for
patients with endocarditis and cardiac device
infections was created. Primary members of the
multidisciplinary
endocarditis
team
after
September 2020 included faculty from the
2

division of infectious diseases, cardiology and
addiction medicine as well as the departments of
cardiac surgery, neurology and psychiatry. This
group met virtually for an hour once per week on
Tuesday afternoons. In addition to providing
antimicrobial recommendations, the EVI service
also coordinated care between the other specialties. The EVI team ensured that cardiac surgery
and addiction medicine were consulted in all
cases of injection drug use related endocarditis
and emailed all team members as well as patients’
primary teams with the list of patients to be presented ~24 hours before the multidisciplinary
endocarditis team meeting. The faculty member
on service for the EVI team moderated the discussion during the meeting and helped to achieve
a consensus plan from the involved providers.
The multidisciplinary team made recommendations about the type and duration of antimicrobial
therapy, whether such therapy could be given in
the outpatient setting, the role and timing of valve
surgery, the role of anticoagulation, the need for
additional echocardiographic or neurologic imaging, the role and type of medication for opioid use
disorder, disposition from the hospital if patients
lacked a stable housing situation as well as type
and interval of required specialty follow-up. At
the conclusion of the meeting, an advanced practice provider working with the EVI service would
document a brief note including the team’s recommendations in the patient’s electronic medical
record.
Pregnant patients with endocarditis were admitted to Magee Women’s Hospital at UPMC.
Notably, this hospital is a separate physical building ~0.5 miles from the Presbyterian and
Montefiore Hospitals where the multidisciplinary
endocarditis team is based. Magee Women’s
Hospital has separate infectious diseases and cardiology consult services as well as a separate
echocardiography lab. In addition, Magee
Women’s Hospital does not have a cardiac surgeon and the cardiac surgeons from Presbyterian
and Montefiore Hospitals do not have privileges
at Magee. Consulting obstetricians are available
at Presbyterian and Montefiore hospitals. When a
pregnant patient was found to have endocarditis,
the cardiologist at Magee interpreting the
echocardiogram contacted the EVI attending
physician who would then add this patient to the
list of patients to be discussed by the multidisciplinary endocarditis team. The EVI attending
physician then notified the endocarditis team’s
journals.sagepub.com/home/tai
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primary cardiac surgeon of the patient so that
they could review the patient’s electronic medical
record prior to the team meeting. The patient’s
primary obstetrician was also invited to attend the
multidisciplinary endocarditis team meeting.
When discussing a pregnant patient, the multidisciplinary endocarditis team also provided guidance about timing of delivery and whether patients
should be transferred from Magee Women’s
Hospital to Presbyterian/Montefiore Hospital, in
addition to the group’s typical recommendations
(described above).
Definitions
Duration of bacteremia was defined by the number of days that elapsed between the first positive
blood culture and two consecutive negative blood
cultures, or a single negative blood culture if only
one was obtained. Valve surgery indications were
defined in accordance with American Heart
Association recommendations.10

had both mitral and tricuspid valve vegetations
and one patient had isolated mitral valve endocarditis. Five patients had septic pulmonary emboli
on chest computerized tomography. Three
patients had radiographic evidence of cerebral
emboli, including two who presented clinically
with stroke, one of whom suffered an intracranial
hemorrhage. Five patients required intensive care
unit admission and required mechanical ventilatory support. The average duration of bacteremia
was 5.8 days (median: 5.5 days, range: 2–12 days).
Three patients underwent uncomplicated
transesophageal echocardiography as part of their
diagnostic evaluation.

Demographics
Between 1 October 2020 and 1 May 2021 6 pregnant or 30-day post-partum patients with infectious endocarditis were identified. The average
patient age was 29.3 years (median: 28 years,
range: 26–37 years; Table 1). The average gestational age at presentation was 22.6 weeks (median:
26 weeks, range: 6–34 weeks) including 2 patients
who presented in labor. No patients presented
post-partum. All patients had co-morbid injection drug use and carried a mental health disorder
diagnosis. Two patients had prior endocarditis,
and 1 had a bicuspid aortic valve which served as
additional endocarditis risk factors. Five patients
presented to Magee Women’s Hospital initially
and 1 patient presented to Presbyterian/
Montefiore Hospitals. Four of 5 patients initially
admitted to Magee were transferred to
Presbyterian/Montefiore, including 3 who were
immediately post-partum or post-miscarriage and
subsequently underwent valve surgery.

Management
Four patients underwent post-partum valve
replacement as part of their endocarditis treatment at an average of 17.8 days (median:
16.5 days, range: 15–21 days) after admission
(Table 3). Prior to surgery two patients delivered
spontaneously at 34 weeks and 39 weeks, 4 days.
One patient underwent emergency C-section at
28 weeks and 1 miscarried at 10 week, 5 days.
Indications for surgery in patients undergoing
valve replacement included recurrent emboli in
all 4 individuals, 3 of whom had vegetations > 1.0 cm. One patient also had persistent
bacteremia for 7 days. One patient underwent an
isolated tricuspid valve replacement, 1 received a
tricuspid valve replacement with patent foramen
ovale closure, 1 underwent isolated mitral valve
replacement and 1 underwent both tricuspid and
mitral valve replacements. All 4 had extensive
valve destruction at the time of surgery that precluded valve repair. Timing of surgery in patients
with cerebral emboli was determined by the multidisciplinary endocarditis team with input from
cardiac surgery, neurology, and neurosurgery. Of
the 2 patients who were managed medically, both
had persistent bacteremia > 7 days, large vegetations > 1.0 cm and 1 had accompanying heart
failure secondary to severe valve dysfunction.
Since both patients had desired pregnancies surgery was not performed antenatally due to the
potential fetal impact of cardiopulmonary bypass.

Methicillin-susceptible Staphylococcal aureus
(MSSA) was the etiologic pathogen in all patients
(Table 2). Five patients had right-sided endocarditis. Three patients had isolated tricuspid disease
and 1 had pulmonic involvement. One patient

After initial empiric antibiotic therapy all patients
were narrowed to targeted antimicrobial treatment with an anti-staphylococcal beta-lactam.
Three were treated with combination beta-lactam
therapy until blood culture clearance.11,12

Results

journals.sagepub.com/home/tai
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Table 1. Demographic data for pregnant patients with infectious endocarditis managed by the
multidisciplinary endocarditis team at the University of Pittsburgh Medical Center.
Variable

N (%)

Mean

Median

Range

29.3 years

28 years

26–37 years

46 miles

50 miles

5–75 miles

Gestational age at first obstetrics visit

10.9 weeks

9.3 weeks

6 – 17.5weeks

Gestational age at diagnosis

22.6 weeks

26 weeks

6–34 weeks

G4

G4

G2 – G5

Average age at delivery
Race
Black

1 (17)

White

5 (83)

Distance from tertiary care site
Medicaid/Medicare

6 (100)

Gravida-multiparous

6 (100)

Incarceration at the time of pregnancy/
prior to diagnosis

1 (17)

Hypertension

0 (0)

Coronary artery disease

0 (0)

Chronic kidney disease

0 (0)

Obesity

1 (17)

Hepatitis C antibody positive

5 (83)

HIV infection

0 (0)

Rheumatic fever

0 (0)

Thyroid disease

0 (0)

Asthma

0 (0)

Tobacco use

3 (50)

Injection drug use

6 (100)

Mental health disorder

6 (100)

Bicuspid aortic valv

1 (17)

Prosthetic valve

0 (0)

Intracardiac devices

0 (0)

Congenital heart disease

0 (0)

History of endocarditis

2 (33)

Medication assisted treatment of opioid
use disorder

3 (50)

HIV, human immunodeficiency virus.

4
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Table 2. Description of endocarditis and modality of medical therapy for pregnant patients with endocarditis.
Variable

N (%)

Mean

Median

Range

5.8 days

5.5 days

2–12 days

1.9 x 1.2 cm

1.7 x 1 cm

0.5 cm x 0.7
cm to 2 cm
x 2 cm

58%

55%

52%–62%

7 days

7 days

2–15 days

Valve location
Tricuspid

4 (67)

Mitral

2 (33)

Pulmonic

1 (17)

No vegetation visualized
Duration of bacteremia
Organism
MSSA

6 (100)

Average vegetation size

Suspected source
Injection-drug use

6 (100)

Embolic phenomenon
Stroke

3 (50)

Pulmonic septic emboli

5 (87)

Other septic emboli

3 (50)

Mechanical ventilation

5 (83)

Regurgitation severity
Mild

1 (17)

Moderate

2 (33)

Moderate-severe

2 (33)

Severe

1 (17)

Heart failure

1 (17)

Average ejection fraction
Arrhythmia

1 (17)

ICU admission

5 (83)

Average ICU length of stay
Surgical Indication
Heart failure from valve dysfunction

1 (17)

Persistent bacteremia

3 (50)

Abscess/heart block/destructive penetrating lesion

0 (0)
(Continued)

journals.sagepub.com/home/tai
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Table 2. (Continued)
Variable

N (%)

Recurrent emboli despite antibiotic therapy

4 (67)

Large vegetation (>1.0–1.5 cm)

5 (84)

Mean

Median

Range

42 days

42 days

28–56 days

Antimicrobial agents
Oxacillin

5 (83)

Cefazolin

1 (17)

Combination antibiotic therapy

3 (50)

Transition to oral antibiotics

1 (17)

Duration of antimicrobial treatment
Successful completion of antibiotic therapy

5 (83)

Addiction medicine consult

6 (100)

New medication for opioid use disorder started during admission

5 (83)

ICU, Intensive care unit; MSSA, Methicillin-susceptible Staphylococcus aureus.

Maternal outcomes
All 6 patients survived until hospital discharge
and were alive at 90-days after diagnosis. Four
patients remained in the hospital to complete
intravenous antibiotic therapy, including 3 who
underwent valve replacement. One patient was
discharged after ~4 weeks of intravenous oxacillin
on oral antibiotics for an additional 2 weeks.13
One was transferred to another institution closer
to her home after clinical stabilization. In all, 5 of
6 patients were discharged on medication for opioid use disorder. Four patients followed-up with
cardiac surgery, 2 with infectious diseases and 2
with an obstetrician (Table 4). Only one patient
was discharged with a form of contraception.
Two patients developed recurrent endocarditis
with different micro-organisms in the setting of
relapsed injection drug use ~4 and 7 months postoperatively. One of these patients underwent redo
mitral valve replacement and developed endocarditis again 4 months after the second operation
secondary to ongoing injection drug use.
Fetal/neonatal outcomes
Four pregnancies resulted in delivery at an average gestational age of 32.4 weeks (median
31 weeks, range 28–39 weeks; Table 5). There
was one miscarriage at 10 weeks, 5 days and one
patient was lost to follow-up with an unknown
6

pregnancy outcome. Three deliveries were spontaneous vaginal deliveries and 1 was an emergent
c-section secondary to fetal bradycardia. Average
available birthweight for 3 babies was 1816 g
(median 1083 g, range 1050 – 3316 g) with
APGAR scores at 1 and 5-minutes averaging 2.3
and 5.7, respectively (median 1, 7, range (1,2–
5,7, Table 6). Three babies required neonatal
ICU admission with an average length of stay of
44.3 days (median: 46 days, range: 17–70 days).
Two infants met clinical criteria for neonatal respiratory distress syndrome and 2 suffered Grades
1–2 intraventricular hemorrhages. One baby met
diagnostic criteria for neonatal abstinence syndrome. Two mothers were unable to breastfeed
secondary to their ongoing medical issues. A third
mother’s child resided with family members > 60 miles from UPMC Presbyterian/
Montefiore and consequently was unable to
breastfeed. A fourth delivered an infant after discharge from UPMC and the authors could not
ascertain whether or not she chose to breastfeed.
Despite prematurity and long-term antenatal
antibiotic exposure, no infants developed
necrotizing enterocolitis.
Discussion
In this case series we present the 1-year experience with management of infective endocarditis
journals.sagepub.com/home/tai
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Table 3. Mortality, surgical and post-operative outcomes for pregnant patients with endocarditis managed by
the multidisciplinary endocarditis team.
Outcome

N (%)

In hospital mortality

0 (0)

90-day mortality

0 (0)

Average time from admission to cardiac
surgery consultation

Mean

Median

Range

6.8 days

7 days

2–15 days

17.8 days
85 minutes

16.5 days
72 minutes

12–21 days
63–133 minutes

30 days

28 days

17–46 days

Surgical intervention details
Valve replacement

4 (67)

Valve repair

0 (0)

Other (PFO closure)

1 (0)

Time from admission to intervention
Average cardiopulmonary bypass time
CIED required

1 (17)

Intracranial hemorrhage post operatively

1 (17)

Average length of stay
30-day readmission

2 (33)

CIED, cardiac implantable electronic device; PFO, patent foramen ovale.

Table 4. Post-discharge outcomes, including rates of
follow-up, relapsed injection drug use and recurrent
endocarditis for pregnant patients with endocarditis
managed by the multidisciplinary endocarditis team.
Outcome

N (%)

Total number of follow up visits
Emergency department visits

7

Obstetrics visits

2

Cardiology visits

2

Cardiac surgery visits

4

Infectious disease visits

2

Primary care visits

8

Contraception use

1 (17)

30-day readmission

2 (33)

Recurrent endocarditis

2 (33)

Relapsed injection drug use

3 (50)

journals.sagepub.com/home/tai

in pregnancy by a single center multidisciplinary
team. Results are notable for an absence of maternal deaths at 90-days follow-up. This may reflect
a more widespread historical trend in mortality as
diagnostic capability and access to treatment for
endocarditis has improved over time. While the
observed mortality was low, morbidity was
impacted by substantial rates of pulmonary septic
emboli, stroke, ICU admission, and long lengths
of stay.
The epidemiologic results of our study largely
reflect the national trend of IE in pregnancy, with
all cases attributable to injection drug use. Despite
increased rates of OUD screening and availability
of treatment, data suggests that large percentages
of hospitalized pregnant patients do not receive
medication for opioid use disorder.14,15 In our
study, all patients were evaluated by addiction
medicine and 5 were discharged on medication for
opioid use disorder. We still observed a high rate
of relapse and recurrent endocarditis, which is
reflective of the disease course when complicated
by substance use disorders. However, at the time
7
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Table 5. Obstetric outcomes for pregnant patients with endocarditis managed by the multidisciplinary
endocarditis team.
Outcome

N (%)

Mean

Median

Range

Average gestational age at birth

32 weeks

31 weeks

28–39 weeks

Average gestational age at
miscarriage

10 weeks

10 weeks

n/a

Mode of delivery
Spontaneous vaginal delivery

3 (50)

C-section

1 (17)

Unknown

1 (17)

Indication for C-section

Fetal bradycardia

Post-partum hemorrhage

0 (0)

Induction of labor

0 (0)

Stillbirth

0 (0)

Miscarriage/IUFD

1 (17)

Elective termination

0 (0)

IUFD, Intrauterine fetal demise.

Table 6. Fetal outcomes for babies born to mothers with infectious endocarditis whose care was managed by
the multidisciplinary endocarditis team.
Outcome

N (%)

Mean

Median

Range

Mortality

1 (17)

Average Birth weight

1816 g

1083 g

1050–3316 g

Average Apgar Scores (1, 5 minutes)

(2.3, 5.7)

(1, 7)

(1, 2)–(5, 7)

44.3 days

46 days

17–70 days

Corticosteroids administered

1 (17)

Congenital abnormalities

0 (0)

Respiratory distress syndrome

2 (33)

Neonatal abstinence syndrome

1 (17)

Early or late onset sepsis

1 (17)

Interventricular hemorrhage

2 (33)

Neonatal Intensive Care Unit stay required

3 (50)

Average NICU length of stay
Breastfeeding

8

0 (0)

journals.sagepub.com/home/tai
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of this study no patients had died from overdose,
which may be related to the protective effects of
medication for opioid use disorder. In addition,
only 1 patient was discharged with contraception.
It is unclear from our study how many patients
were offered contraception. However, given the
challenges managing endocarditis and cardiac valvular diseases in pregnancy multidisciplinary
endocarditis teams may want to consider performing more detailed assessment of patients’ interest
in contraception prior to hospital discharge.4
With respect to fetal outcomes, the series had
adverse outcomes in all pregnancies, including 1
intrauterine demise. We also observed a high preterm delivery rate, with average gestational age at
live birth of 32 weeks, similar to reported literature.5 This led to further neonatal complications
with half of the neonates requiring ICU admissions and prolonged lengths of stay. There were
substantial rates of low fetal birth weight, low
APGAR scores, respiratory distress syndrome,
and intraventricular hemorrhage. These fetal
complications have been associated with adverse
neurodevelopmental outcomes as well as higher
disability rates in children; however, the longterm pediatric outcomes related to maternal
endocarditis have not been studied.16,17
Access to valve surgery historically has been challenging for both pregnant patients and patients
who inject drugs. However, a highlight of this
series was the high rate of surgical intervention
which occurred in 4 patients. The use of cardiopulmonary bypass and cardiac surgery in pregnancy is still quite controversial, and data on rates
of surgical intervention are limited.3 As discussed
above, cardiac surgery was not available at Magee
Women’s Hospital and the presence of the multidisciplinary endocarditis team facilitated hospital
transfers and provided access to surgical opinions
that would not otherwise have been readily available. Notably, all surgically managed patients in
our series underwent valve surgery after delivery
or miscarriage. With regards to antimicrobial
treatment, 5 patients completed the recommended courses of antibiotic therapy. As a result
of the multidisciplinary endocarditis team, pregnant patient with endocarditis received access to
input from infectious diseases specialists with
expertise in endocarditis. Consequently, 3
patients were treated with combination beta-lactam therapy, a novel approach that has been
shown to decrease time to blood culture clearance
journals.sagepub.com/home/tai

Table 7. Potential benefits of a multidisciplinary endocarditis team on the
care of pregnant patients with endocarditis.
Discipline

Potential Benefit

Cardiac surgery

Increased access to valve surgery

Obstetrics

Decreased maternal mortality

Infectious diseases

Selection for oral antibiotics
Combination antibiotic therapy

Addiction medicine

Increased access to medication for opioid use
disorder

Hospital medicine

Decreased patient directed discharges

and is associated with low-mortality in patients
with MSSA endocarditis.11,12 Historically patients
with injection drug use and/or pregnancy have
high rates of patient-directed discharges and failure of antibiotic completion.18,19 Encouragingly,
there were no patient-directed discharges after
involvement of the multidisciplinary endocarditis
team.
While this is a small case series assessing the
impact of multidisciplinary teams in caring for
pregnant or post-partum patients with endocarditis, it extends existing evidence demonstrating the
benefits of these teams on patient outcomes.
While more robust clinical trials are needed, given
the challenges conducting intervention research
in both pregnant patients and individuals with
endocarditis it may be difficult to obtain high
quality data. In the interim, multidisciplinary
endocarditis teams are a low-risk intervention
that may improve outcomes in this population
(Table 7).
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